首页> 外国专利> Production of optically active 2-(2,5-dioxo-1-imidazolidinyl)acetic acid derivatives, useful as pharmaceutical intermediates, comprises stereoselective enzymatic hydrolysis of a mixture of enantiomers with an esterase

Production of optically active 2-(2,5-dioxo-1-imidazolidinyl)acetic acid derivatives, useful as pharmaceutical intermediates, comprises stereoselective enzymatic hydrolysis of a mixture of enantiomers with an esterase

机译:用作药物中间体的旋光性2-(2,5-二氧代-1-咪唑啉基)乙酸衍生物的制备包括对映异构体与酯酶混合物的立体选择性酶水解

摘要

Production of optically active 2-(2,5-dioxo-1-imidazolidinyl)acetic acid derivatives (I), comprises: (1) enzymatic hydrolysis of a mixture of enantiomers with an esterase: and (2) separation of the converted and unconverted compounds from each other. Production of optically active 2-(2,5-dioxo-1-imidazolidinyl)acetic acid derivatives of formula (I), comprises: (1) enzymatic hydrolysis of a mixture of enantiomers of formula (I;R3=R3') with an esterase: and (2) separation of the converted and unconverted compounds from each other. R1 = H, F, or 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl or 3-4C cycloalkyl (optionally substituted by 1-3 of F, Cl, Br and Me); R1+R1 = (CH2)4 or (CH2)5; R2 = F, Cl, Br, NO2, CN, OH, OMe, acetylamino, t-butoxycarbonylamino, benzyloxycarbonylamino, SMe, t-butylthio, 1-10C alkyl, aryl, aryl(1-10C)alkyl, heteroaryl, heteroaryl(1-10C)alkyl, 2-10C alkenyl, 2-10C alkynyl, 3-7C cycloalkyl or (3-7C)cycloalkyl(1-10C)alkyl optionally substituted with 1-3 of halo, CF3, Me, NO2, CN, acetylamino, 9-fluorenylmethoxycarbonyl, t-butoxycarbonylamino, benzyloxycarbonylamino, SH, SMe, t-butylthio, OH, OMe, OEt or COOR4; R3 = H or R3'; R3' = 1-10C alkyl, aryl(1-10C)alkyl, 2-10C alkenyl, 2-10C alkynyl, 3-7C cycloalkyl or (3-7C)cycloalkyl(1-10C)alkyl optionally substituted with 1-3 of halo, CF3, Me, NO2, CN, acetylamino, t-butoxycarbonylamino, benzyloxycarbonylamino, SH, SMe, t-butylthio, OH, OMe, OEt and COOR5; and R4, R5 = H, 1-4C alkyl, 2-4C alkenyl or aryl(1-10C)alkyl.
机译:光学活性的2-(2,5-二氧代-1-咪唑啉基)乙酸衍生物的制备(I)包括:(1)对映体混合物与酯酶的酶促水解;和(2)分离转化的和未转化的彼此的化合物。式(I)的光学活性的2-(2,5-二氧代-1-咪唑啉基)乙酸衍生物的制备包括:(1)将式(I; R3 = R3')的对映异构体与酯酶:和(2)将转化的和未转化的化合物彼此分离。 R 1 = H,F或1-4C烷基,2-4C烯基,2-4C炔基或3-4C环烷基(任选地被F,Cl,Br和Me中的1-3取代); R 1 + R 1 =(CH 2)4或(CH 2)5; R 2 = F,Cl,Br,NO 2,CN,OH,OMe,乙酰氨基,叔丁氧羰基氨基,苄氧羰基氨基,SMe,叔丁硫基,1-10C烷基,芳基,芳基(1-10C)烷基,杂芳基,杂芳基(1-10C)烷基,2-10C烯基,2-10C炔基,3-7C环烷基或(3-7C)环烷基(1-10C)烷基,可任选被1-3个卤素,CF3,Me,NO2取代, CN,乙酰氨基,9-芴基甲氧基羰基,叔丁氧基羰基氨基,苄氧基羰基氨基,SH,SMe,叔丁硫基,OH,OMe,OEt或COOR 4; R 3 = H或R 3'; R3′= 1-10C烷基,芳基(1-10C)烷基,2-10C烯基,2-10C炔基,3-7C环烷基或(3-7C)环烷基(1-10C)烷基,其任选地被1-3个取代卤素,CF 3,Me,NO 2,CN,乙酰氨基,叔丁氧羰基氨基,苄氧羰基氨基,SH,SMe,叔丁硫基,OH,OMe,OEt和COOR 5; R 4,R 5 = H,1-4C烷基,2-4C烯基或芳基(1-10C)烷基。

著录项

  • 公开/公告号DE10134366A1

    专利类型

  • 公开/公告日2003-01-23

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA DEUTSCHLAND GMBH;

    申请/专利号DE2001134366

  • 发明设计人 HOLLA WOLFGANG;

    申请日2001-07-14

  • 分类号C07D233/72;

  • 国家 DE

  • 入库时间 2022-08-21 23:42:48

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号